Skip to content
Some content is members-only. Sign in to access.

Meta Bull Case Intact, Bear Case Is Funding Risk

26% revenue growth and pricing power versus negative cash flow and dilution

By KAPUALabs

The evidence on Meta Platforms comes mostly from the first half of November 2026. It describes one tension. The operating business is growing quickly, and the sell-side is overwhelmingly constructive. But the 2026 spending programme is large enough to have pushed free cash flow negative, stopped buybacks and sent the company to the equity and debt markets. The stock fell hard after the third-quarter report and has since bounced. Its forward multiple has compressed to roughly 17–21x. My reading is that the market is paying for the growth but charging for the funding risk. That reading is interpretation, and I flag where the evidence stops and my inference begins.

The Engine: Growth That Is Not in Dispute

Third-quarter revenue was $64.6 billion 164,167,179,241, about 26% higher year over year 243,257. That beat the Zacks consensus of $63.41 billion by 1.88% 167. Price per ad rose 12%, a figure corroborated by five sources 105,106,135,136,257. Advertising is more than 98% of revenue 7,8,11,19,21,27,28,33,34,37,38,48,108,113,122,148,214,217, on a base of over 3.5 billion daily active users 1,3,4,49,57,64,68,79,82,84,86,87,91,98,102,103,104,105,106,107,108,113,133,139,143,152,153,257. Net margin is 31.15% 186,199,204.

Expectations run ahead of this. Consensus has current-fiscal-year sales at $256.32 billion, up 27.5% 167. Demand and pricing power are therefore not what the market is arguing about. The argument is about what it costs to sustain that growth, and who pays.

The Funding Squeeze: Spending That Outruns Internal Cash

The size of the commitment

The 2026 capex guidance of $115–$135 billion is the most heavily corroborated claim in the material, with 51 sources 5,20,41,54,76,78,80,81,83,85,88,92,94,96,109,111,112,113,116,117,119,121,125,130,132,134,139,140,141,142,146,154,157,158,229,258. It was maintained 245 and implies about 94% year-over-year growth at the midpoint 245. Third-quarter capex alone was $34.9 billion 232. Over the trailing twelve months, capex of $104.4 billion sits against operating cash flow of $133.1 billion 178. Free cash flow turned negative in the latest quarter 222,258, and the trailing ratio of free cash flow to operating cash flow is only 0.21 178.

The financing response

Meta acknowledged it would need up to $100 billion of new equity capital for planned 2027 capex 172,197. The steps that followed are visible in the evidence:

Buybacks were zero in the third quarter 232, and trailing repurchases are zero 178. In FY2025 the company repurchased $26.2 billion 178. This is the clearest sign of a change in capital allocation, from returning cash to raising it.

The equity was sold close to the market. Meta priced $25 billion of Class A stock at $625 per share through forward sale agreements 171,187,188. The forwards started at 40m shares 175 and grew to 46m once the additional-share option was exercised on 4 November 171,175. Against roughly 2.56 billion common shares 171, that is a small fraction of the count. The 4 November close was $630.00 185. One note says an earlier $15 billion sale priced about 4x covered 213, which suggests demand for Meta paper is strong. Two single-sourced items point to more supply: a potential further $60 billion of stock sales through an at-the-market programme 212, and a reported 2-for-1 split planned for January, with 2027 implied 170. The supplied material does not say what drove the sell-off. It also does not explain the use of proceeds.

Credit

Credit is the quieter part of the story. S&P revised its outlook from stable to negative on six sources 189,190,216,218,220,221 while keeping the rating at AA- 216. The reported balance-sheet strain is modest: net debt of $5.59 billion 13,59,259 and interest coverage of 28.6x 230. One post claims $121 billion is owed in 2027 254. It has a single source and no supporting detail, so I give it no weight. Taken together, this looks like a strong balance sheet being deliberately reshaped to fund a capex programme larger than the cash the business generates. It does not look like a stressed one.

The Print: A Contested EPS Figure

The earnings per share figure is the least settled number in the material. One source shows reported EPS of $3.83 against an estimate of $5.42 205. Another reports $7.40, a 13.5% surprise 167. A third says EPS would have been about $7.40 excluding a sizable legal charge tied to teen-safety litigation 258. A fourth cites underlying EPS of about $7.40 without describing the charge 201. The sources do not reconcile the gap in one place. The legal-charge account is the most plausible reading, and it matches one commentator's view that the soft quarter reflected a legal charge and not the business 252. Separately, Meta faces a proposed Italian fine, cited as €880 million 191 and as $887 million 253.

The market's reaction was sharp but within range. The stock fell about 7% in a session 195,203,226, less than the roughly ±8% the options market had priced 195. Realised moves over the last four reports averaged 9.6% in absolute terms, and three of the four were down 166. The fall was unwelcome, but it was not out of character.

The Price Path: A Peak, a Drawdown, a Short Rebound

The September peak was near $780. One source gives an intraday high of $779.82 on 24 September 192 and a closing high of $777.59 192. Another has a $769.22 close that day 196. The sources differ on the October level too. One has $762.50 on 13 October, followed by a 15.8% fall over the next month 192. Another has $742.96 that day 196. These differences are small beside the shape of the move: a rally of about 37% over the prior month 196, then a reset.

The low area came on 6 November, when the stock closed at $610.15 228,238. A 5% surge followed on 9 November, the day JPMorgan added Meta to its Analyst Focus List 181,183,184,231,234,235. JPMorgan cited AI-powered advertising performance 208. On 13 November the stock gained 2.90% to close at $641.69 193,205,211. It was the one large name in the green on a day when most of tech fell 248,249. The week from 6 to 13 November brought a gain of 5.2% 192, yet the stock remains about 17–19% below its high 246,260. Year to date it is slightly negative, at -2.79% 211 or -4.74% 215.

The 52-week low of $520.26 is well corroborated, with 43 sources 22,23,24,35,39,40,45,46,52,53,56,60,67,69,73,75,76,77,95,97,109,110,120,155,158,206. The 52-week high is reported inconsistently: $779.82 207, about $780 206, $790 94,240 and $742.68 60,99,100,101,118,151,194. I treat it as roughly $780, in line with the September peak.

Valuation: Cheap Against Which Benchmark?

The multiples are scattered, and most are thinly sourced. The pattern is more reliable than any single figure. Forward multiples typically sit at 17–19x 225,230,244,247,248,256, with 16.4x at the low end 82,208,224 and about 21x at the high end 255. The most corroborated individual readings are about 19x on five sources 159,160,162,168 and about 20.6x on four 161,163,166,192. Trailing multiples cluster around 20–22x 144,149,156,157,174,198,202,236,242, though 25.8x is also widely repeated 2,16,17,18,21,25,32,36,43,44,75,89,90,126,137,138,206.

Against Meta's own history, the discount is real. The forward multiple is 12% below its three-year average on two sources 250, and the five-year average forward multiple is 21x 184. Against peers, the answer depends on who is in the comparison:

The discount also shows up in earnings multiples more than in enterprise value. Trailing EV/EBITDA of 15.9x is roughly in line with its three-year average 250. Price to free cash flow is about 57x 250, which is what negative free cash flow does to a cash-based multiple.

Intrinsic-value estimates scatter widely. A Simply Wall St narrative gives $1,018.71 208,209, a community model $722.62 260, and one independent author $650.59, only about 1.3% above the then price 240. The most disciplined framing is a reverse DCF. It requires EPS to compound at 17.8% a year for five years 219, against a trailing five-year EPS trend of +26.4% a year 239. The market is not demanding heroics, but it is demanding that growth continue.

The Sell-Side: Bullish, With Dissent

Consensus targets land at $830–$860 50,55,63,72,182,190,199,204,214,257, with the average cited at $850.10 169. That is far above $641.69. Individual targets include Wells Fargo at $995 177,206, J.P. Morgan at $940 177,183,206, Goldman Sachs at $885 177,204,206 and Barclays at $780 131,177,206. The J.P. Morgan target equals about 22x 2028 EPS estimates 184. Dissent is visible: Wolfe Research at $700 186 and BMO at $580 with a Hold rating 206. Provider labels differ, from "Strong Buy" by 55 analysts 9,29,61,93,257 to "Moderate Buy" 61,71,204 and Zacks Rank #3 (Hold) 6,12,41,42,51,58,62,70,74,114,167. The substance is consistent, and there are no meaningful Sells 177.

Estimate revisions pull in two directions. One series shows EPS estimates for the compared period falling from $7.25 a year earlier to $6.35 on 7 October and $5.89 on 21 October 196. Yet 2027 estimates had seven upward revisions in the preceding 30 days on two sources 168, and 2026 estimates were raised seven times over the same period 169. The material does not reconcile these. Timing and definitions, including the legal charge, are the likely cause, but that is inference.

The Technical Band

The technical evidence agrees on where the contest is. The 200-day average is about $630.77 192 or about $632 177. Resistance is placed at $648, a level cited across four sources 200. Support is cited at $609–610 200 and around the $600 threshold 200, with Fibonacci levels near $594 200. The stock trades below its 50-day average, a point corroborated by 32 sources 13,26,30,31,47,50,115,119,123,126,127,128,145,147,150,152,155,204. One source puts that average at $679.81 and falling 192.

The sources disagree about the 200-day line. Some say Meta is below it 200,237, while another says it reclaimed the line on 9 November 192. Different observation dates are the likeliest explanation, though the material does not settle it. Momentum readings conflict too, from a 14-day RSI of 47.8 192 to claims of a daily RSI of 24 200. Flows are mixed: Soros increased its stake in the third quarter 251, while insiders sold $24 million of stock 50,124,129,260.

What It Implies

Taken together, the evidence suggests the market is no longer arguing about whether Meta can grow. It is asking whether $115–$135 billion of annual capex 5,20,41,54,76,78,80,81,83,85,88,92,94,96,109,111,112,113,116,117,119,121,125,130,132,134,139,140,141,142,146,154,157,158,229,258 earns a return adequate to the dilution, the lost buybacks and the negative credit outlook it brings. The timing supports that reading: the drawdown ran alongside the earnings print and the capital-raising announcements. But the material never states a causal link, and I offer it as inference.

On that reading, a forward multiple in the high teens means investors are not extrapolating the growth in full. That is where consensus targets above $800 and the JPMorgan endorsement matter. The re-rating case rests mainly on comparisons with Microsoft and Amazon. It is much thinner against Alphabet and the ex-AI index. It also depends on the financing overhang easing, and the possible $60 billion at-the-market programme 212 is a reminder that more equity supply may still come.

Three things will decide whether the discount closes. The first is whether the stock holds the band between the $625 issue price and the $648 resistance, with the 200-day average in the middle. The second is whether the 2026–2027 upward revisions 168,169 prevail over the earlier downward ones. The third is how the legal and regulatory items, the teen-safety charge and the Italian fine, resolve. The rebound is only days old. The test of Meta's capital allocation lies in the returns on that spending, which will show up over years.

More from KAPUALabs

See all
| Free

Meta’s AI Build-Out: Ad Gains Versus Funding Strain

By KAPUALabs
/
| Free

Italy’s Meta Ruling: Consent, Remedy and Regulatory Reach

By KAPUALabs
/
| Free

Meta Bull Case Holds on Ads, Bear Case on Spending

By KAPUALabs
/